Skip to main content

Clearmind Medicine Inc.

corporate_fare Company Profile

Clearmind Medicine Inc.

Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; Yissum Research Development Company of the Hebrew University of Jerusalem to develop, manufacture, and commercialize compounds targeted at treating post traumatic stress disorder and other health conditions. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is based in Vancouver, Canada.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed CMND - Latest Insights

CMND
Apr 27, 2026, 7:45 AM EDT
Filing Type: 6-K
Importance Score:
7
CMND
Apr 27, 2026, 7:41 AM EDT
Source: GlobeNewswire
Importance Score:
7
CMND
Apr 21, 2026, 6:57 AM EDT
Filing Type: 6-K
Importance Score:
9
CMND
Apr 20, 2026, 5:18 PM EDT
Filing Type: 6-K
Importance Score:
9
CMND
Apr 20, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
8
CMND
Apr 15, 2026, 9:15 AM EDT
Filing Type: 6-K
Importance Score:
8
CMND
Apr 15, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
CMND
Apr 15, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
CMND
Apr 14, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
9
CMND
Apr 14, 2026, 8:23 AM EDT
Filing Type: 6-K
Importance Score:
8
CMND
Apr 14, 2026, 7:32 AM EDT
Source: GlobeNewswire
Importance Score:
9
CMND
Mar 30, 2026, 9:27 AM EDT
Filing Type: 6-K
Importance Score:
7
CMND
Mar 30, 2026, 8:32 AM EDT
Source: GlobeNewswire
Importance Score:
7
CMND
Mar 27, 2026, 7:32 AM EDT
Source: GlobeNewswire
Importance Score:
7
CMND
Mar 19, 2026, 8:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
CMND
Mar 17, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
CMND
Mar 16, 2026, 7:30 AM EDT
Source: The newswire.ca
Importance Score:
7
CMND
Mar 12, 2026, 4:16 PM EDT
Filing Type: 6-K
Importance Score:
8
CMND
Mar 11, 2026, 9:07 AM EDT
Source: GlobeNewswire
Importance Score:
7
CMND
Mar 10, 2026, 8:59 AM EDT
Source: GlobeNewswire
Importance Score:
7